520 related articles for article (PubMed ID: 23686496)
1. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
2. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
[TBL] [Abstract][Full Text] [Related]
4. Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1.
Vago JP; Tavares LP; Sugimoto MA; Lima GL; Galvão I; de Caux TR; Lima KM; Ribeiro AL; Carneiro FS; Nunes FF; Pinho V; Perretti M; Teixeira MM; Sousa LP
J Immunol; 2016 Feb; 196(4):1922-32. PubMed ID: 26800869
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells.
Tsai WH; Chien HY; Shih CH; Lai SL; Li IT; Hsu SC; Kou YR; Hsu HC
J Cell Physiol; 2012 Nov; 227(11):3661-9. PubMed ID: 22378018
[TBL] [Abstract][Full Text] [Related]
7. The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia.
Machado MG; Tavares LP; Souza GVS; Queiroz-Junior CM; Ascenção FR; Lopes ME; Garcia CC; Menezes GB; Perretti M; Russo RC; Teixeira MM; Sousa LP
FASEB J; 2020 Feb; 34(2):2749-2764. PubMed ID: 31908042
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
[TBL] [Abstract][Full Text] [Related]
9. Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
Vital SA; Becker F; Holloway PM; Russell J; Perretti M; Granger DN; Gavins FN
Circulation; 2016 May; 133(22):2169-79. PubMed ID: 27154726
[TBL] [Abstract][Full Text] [Related]
10. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct.
Gavins FN; Kamal AM; D'Amico M; Oliani SM; Perretti M
FASEB J; 2005 Jan; 19(1):100-2. PubMed ID: 15507472
[TBL] [Abstract][Full Text] [Related]
11. Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A
Hughes EL; Becker F; Flower RJ; Buckingham JC; Gavins FNE
Br J Pharmacol; 2017 Jul; 174(14):2393-2408. PubMed ID: 28471519
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.
Zharkova O; Salamah MF; Babak MV; Rajan E; Lim LHK; Andrade F; Gil CD; Oliani SM; Moraes LA; Vaiyapuri S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834844
[TBL] [Abstract][Full Text] [Related]
13. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation.
McArthur S; Gobbetti T; Kusters DH; Reutelingsperger CP; Flower RJ; Perretti M
J Immunol; 2015 Aug; 195(3):1139-51. PubMed ID: 26101324
[TBL] [Abstract][Full Text] [Related]
14. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.
Gastardelo TS; Damazo AS; Dalli J; Flower RJ; Perretti M; Oliani SM
Am J Pathol; 2009 Jan; 174(1):177-83. PubMed ID: 19095957
[TBL] [Abstract][Full Text] [Related]
15. Annexin A1 promotes timely resolution of inflammation in murine gout.
Galvão I; Vago JP; Barroso LC; Tavares LP; Queiroz-Junior CM; Costa VV; Carneiro FS; Ferreira TP; Silva PM; Amaral FA; Sousa LP; Teixeira MM
Eur J Immunol; 2017 Mar; 47(3):585-596. PubMed ID: 27995621
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.
Gavins FN; Hughes EL; Buss NA; Holloway PM; Getting SJ; Buckingham JC
FASEB J; 2012 Dec; 26(12):4977-89. PubMed ID: 22964301
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide.
Perretti M; Di Filippo C; D'Amico M; Dalli J
PLoS One; 2017; 12(4):e0175786. PubMed ID: 28407017
[TBL] [Abstract][Full Text] [Related]
18. Annexin-A1: Therapeutic Potential in Microvascular Disease.
Purvis GSD; Solito E; Thiemermann C
Front Immunol; 2019; 10():938. PubMed ID: 31114582
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
Bena S; Brancaleone V; Wang JM; Perretti M; Flower RJ
J Biol Chem; 2012 Jul; 287(29):24690-7. PubMed ID: 22610094
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
Costa VV; Sugimoto MA; Hubner J; Bonilha CS; Queiroz-Junior CM; Gonçalves-Pereira MH; Chen J; Gobbetti T; Libanio Rodrigues GO; Bambirra JL; Passos IB; Machado Lopes CE; Moreira TP; Bonjour K; Melo RCN; Oliveira MAP; Andrade MVM; Sousa LP; Souza DG; Santiago HDC; Perretti M; Teixeira MM
Elife; 2022 Mar; 11():. PubMed ID: 35293862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
